NEW YORK (GenomeWeb) – LGC announced today that it has acquired Berry and Associates in order to strengthen its nucleic acid chemistry portfolio.
Financial terms of the deal were not disclosed.
Dexter, Michigan-based Berry sells oligo reagents to customers in the pharmaceutical, clinical diagnostics, and academic research sectors. It also sells products to oligonucleotide synthesis companies and contract manufacturing organizations. The firm, which was founded in 1989, employs 14 people.